These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31679618)

  • 21. Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety.
    Moore K; Ganesan A; Labrosciano C; Heddle W; McGavigan A; Hossain S; Horton D; Hariharaputhiran S; Ranasinghe I
    J Am Heart Assoc; 2019 Jan; 8(2):e010869. PubMed ID: 30648465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of Frailty to Cost for Patients Undergoing Transcatheter Aortic Valve Implantation.
    Patel JN; Ahmad M; Kim M; Banga S; Asche C; Barzallo M; Mungee S
    Am J Cardiol; 2020 Feb; 125(3):469-474. PubMed ID: 31806209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Frailty and Surgical Outcomes Across Diverse Surgical Subspecialties in a Large Health Care System.
    Mrdutt MM; Papaconstantinou HT; Robinson BD; Bird ET; Isbell CL
    J Am Coll Surg; 2019 Apr; 228(4):482-490. PubMed ID: 30885474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of Early Cardiac Implantable Electronic Device Lead Dislodgement in the Elderly.
    Mlynarski R; Mlynarska A; Joniec M; Gladysz-Wanha S; Honkowicz M; Stachanczyk J; Golba KS
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frailty, Physical Activity, and Mobility in Patients With Cardiac Implantable Electrical Devices.
    Kramer DB; Tsai T; Natarajan P; Tewksbury E; Mitchell SL; Travison TG
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28188253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors and Outcomes of Patients Requiring a Permanent Pacemaker After Aortic Valve Replacement in the United States.
    Robich MP; Schiltz NK; Johnston DR; Mick S; Krishnaswamy A; Iglesias RA; Hang D; Roselli EE; Soltesz EG
    J Card Surg; 2016 Aug; 31(8):476-85. PubMed ID: 27335256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.
    Voigt A; Shalaby A; Saba S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):414-9. PubMed ID: 19793359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac implantable electronic device infections: Who is at greatest risk?
    Joy PS; Kumar G; Poole JE; London B; Olshansky B
    Heart Rhythm; 2017 Jun; 14(6):839-845. PubMed ID: 28315744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low lateral thoracic site for cardiac implantable electronic device implantation: A viable alternative in patients with limited access options after infected device extraction.
    Liang JJ; Schaller RD; Modi DS; Enriquez A; Supple GE; Cooper JM
    Heart Rhythm; 2017 Oct; 14(10):1506-1514. PubMed ID: 28603001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
    Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Chronic Thrombocytopenia on Outcomes After Transcatheter Valvular Intervention and Cardiac Devices Implantation (From a National Inpatient Sample).
    Shokr M; Adegbala O; Elmoghrabi A; Saleh M; Ajam M; Ali A; Yassin AS; Ando T; Eperjesiova B; Aly A; Pahuja M; Ashraf S; Abubakar H; Ahmed A; Subahi A; Lieberman R; Afonso L
    Am J Cardiol; 2019 Nov; 124(10):1601-1607. PubMed ID: 31522774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.
    Le KY; Sohail MR; Friedman PA; Uslan DZ; Cha SS; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM;
    Heart Rhythm; 2011 Nov; 8(11):1678-85. PubMed ID: 21699855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S.
    Sridhar AR; Lavu M; Yarlagadda V; Reddy M; Gunda S; Afzal R; Atkins D; Gopinathanair R; Dawn B; Lakkireddy DR
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):286-293. PubMed ID: 28084622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac implantable electronic devices in adults with tetralogy of Fallot.
    Egbe AC; Miranda WR; Madhavan M; Ammash NM; Missula VR; Al-Otaibi M; Fatola A; Kothapalli S; Connolly HM
    Heart; 2019 Apr; 105(7):538-544. PubMed ID: 30377259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias.
    Goldenberg I; Moss AJ; Maron BJ; Dick AW; Zareba W
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4 Suppl):67-83. PubMed ID: 16274418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors, Morbidity, and Costs Associated with Pneumothorax during Electronic Cardiac Device Implantation.
    Kotter J; Lolay G; Charnigo R; Leung S; McKibbin C; Sousa M; Jimenez L; Gurley J; Biase LD; Natale A; Smyth S; Darrat Y; Morales G; Elayi CS
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):985-91. PubMed ID: 27230623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
    Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience.
    Archontakis S; Oikonomou E; Sideris K; Laina A; Tirovola D; Paraskevopoulou D; Kostakis P; Doundoulakis I; Arsenos P; Ntalakouras I; Charitakis E; Gatzoulis K; Tsioufis K; Sideris S
    J Interv Card Electrophysiol; 2023 Mar; 66(2):471-481. PubMed ID: 36063282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redo procedures and chronic renal dysfunction are associated with higher risk of cardiac electronic device infections.
    Morani G; Mugnai G; Bolzan B; Morosato M; Tomasi L; Ferrari S; Vassanelli C
    Minerva Cardioangiol; 2018 Jun; 66(3):225-232. PubMed ID: 29308851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy.
    Brambatti M; Mathew R; Strang B; Dean J; Goyal A; Hayward JE; Long L; DeMeis P; Smoke M; Connolly SJ; Morillo CA; Amit G; Capucci A; Healey JS
    Heart Rhythm; 2015 Oct; 12(10):2148-54. PubMed ID: 26049049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.